rs369165766
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001458.5(FLNC):c.5262C>A(p.Tyr1754*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001458.5 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLNC | NM_001458.5 | c.5262C>A | p.Tyr1754* | stop_gained | Exon 31 of 48 | ENST00000325888.13 | NP_001449.3 | |
FLNC | NM_001127487.2 | c.5200-346C>A | intron_variant | Intron 30 of 46 | NP_001120959.1 | |||
FLNC-AS1 | NR_149055.1 | n.*124G>T | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLNC | ENST00000325888.13 | c.5262C>A | p.Tyr1754* | stop_gained | Exon 31 of 48 | 1 | NM_001458.5 | ENSP00000327145.8 | ||
FLNC | ENST00000346177.6 | c.5200-346C>A | intron_variant | Intron 30 of 46 | 1 | ENSP00000344002.6 | ||||
FLNC-AS1 | ENST00000469965.1 | n.*124G>T | downstream_gene_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Cardiovascular phenotype Uncertain:1
The p.Y1754* variant (also known as c.5262C>A), located in coding exon 31 of the FLNC gene, results from a C to A substitution at nucleotide position 5262. This changes the amino acid from a tyrosine to a stop codon within coding exon 31. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. However, pathogenicity has not been established for alterations in exon 31 of FLNC. The exon is alternatively spliced, and the predominant isoform expressed in healthy human cardiac tissue does not include exon 31 (Kong SW et al. Circ Cardiovas Genet. 2010 Apr;3(2):138-46). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.